The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Duchemin Jeffrey since 2015.
The trader's CIK number is 1585223.
At the time of the last reporting, Duchemin Jeffrey was the Chief Executive Officer of Harvard Bioscience Inc. (stock ticker symbol HBIO).
Also see all insider trading activities at Harvard Bioscience Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | HBIO | 0 | $0 | 19,157 | $86,390 | 0 | $0 |
| 2018 | HBIO | 0 | $0 | 277,022 | $1,534,485 | 150,000 | $646,497 |
| 2017 | HBIO | 22,000 | $60,719 | 22,000 | $58,520 | 0 | $0 |
| 2016 | HBIO | 15,000 | $36,300 | 0 | $0 | 0 | $0 |
| 2015 | HBIO | 12,000 | $42,520 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-04-10 | HBIO | Sale | 6,332 | 4.50 | 28,494 |
| 2019-04-11 | HBIO | Sale | 12,425 | 4.51 | 56,036 |
| 2019-04-12 | HBIO | Sale | 400 | 4.65 | 1,860 |
| 2018-08-07 | HBIO | Option Ex | 100,000 | 4.31 | 430,999 |
| 2018-08-08 | HBIO | Option Ex | 5,500 | 4.31 | 23,704 |
| 2018-08-07 | HBIO | Sale | 100,000 | 6.07 | 607,000 |
| 2018-08-09 | HBIO | Option Ex | 44,500 | 4.31 | 191,794 |
| 2018-08-08 | HBIO | Sale | 5,500 | 6.35 | 34,925 |
| 2018-08-09 | HBIO | Sale | 44,500 | 6.41 | 285,245 |
| 2018-07-09 | HBIO | Sale | 14,195 | 5.41 | 76,794 |
| 2018-07-10 | HBIO | Sale | 11,600 | 5.38 | 62,408 |
| 2018-07-11 | HBIO | Sale | 14,205 | 5.22 | 74,150 |
| 2018-03-09 | HBIO | Sale | 7,800 | 4.60 | 35,880 |
| 2018-03-08 | HBIO | Sale | 79,222 | 4.52 | 358,083 |
| 2017-06-12 | HBIO | Buy | 22,000 | 2.76 | 60,719 |
| 2017-06-12 | HBIO | Sale | 22,000 | 2.66 | 58,520 |
| 2016-11-03 | HBIO | Buy | 15,000 | 2.42 | 36,300 |
| 2015-12-10 | HBIO | Buy | 10,000 | 3.37 | 33,700 |
| 2015-09-02 | HBIO | Buy | 2,000 | 4.41 | 8,820 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duchemin Jeffrey (Chief Executive Officer of Harvard Bioscience Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.